Association of Race and Postoperative Outcomes in Patients with Inflammatory Bowel Disease

被引:1
|
作者
Newland, John J. [1 ]
Sundel, Margaret H. [1 ]
Blackburn, Kyle W. [2 ]
Vessilenov, Roumen [3 ]
Eisenstein, Samuel [4 ]
Bafford, Andrea C. [5 ]
机构
[1] Univ Maryland, Med Ctr, Baltimore, MD 21201 USA
[2] Baylor Coll Med, Houston, TX USA
[3] Univ Maryland, Sch Pharm, Baltimore, MD USA
[4] Univ Calif San Diego, Dept Surg, La Jolla, CA USA
[5] Johns Hopkins Univ, Dept Surg, Sch Med, Baltimore, MD USA
基金
美国国家卫生研究院;
关键词
Inflammatory bowel disease; Crohn's disease; Ulcerative colitis; Surgical complications; Race; IMPACT; IBD; DISPARITIES; MORTALITY; SURGERY;
D O I
10.1007/s10620-024-08594-4
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BackgroundPrevious literature suggests that rates of postoperative complications following inflammatory bowel disease (IBD) surgery differ based on race.AimsThe purpose of this study was to examine the association between race and adverse events and wound complications in patients with IBD.MethodsThis was a retrospective cohort study of the American College of Surgeons National Surgery Quality Improvement Program Inflammatory Bowel Disease Collaborative from 2017 to 2022. The data was collected from 15 high-volume IBD centers across the United States. The data was analyzed using crude and multivariable logistic regressions.Results4284 patients were included in the study. Overall rates of adverse events and wound complications were 20.3% and 11.3%, respectively, and did not differ based on race on bivariate analysis. Rates of adverse events were 20.0% vs 24.6% vs 22.1%, p = 0.13 for white, black and other minority subjects, respectively. The adjusted odds of adverse events were higher for black subjects (1.46 [95%CI 1.0-2.1], p = 0.03) compared to white subjects. No difference in adverse events was found between other minority subjects and either black or white subjects (1.29 [0.7-2.3], p = 0.58). Race was not associated with likelihood of wound complications in the final analysis.ConclusionsWe found that a subset of black patients with IBD continue to experience more adverse events compared to white patients, primarily driven by a higher need for postoperative blood transfusion. Nonetheless, known risk factors, including comorbid conditions, decreased BMI, open surgery, and emergency surgery have a stronger association with postoperative complications than race alone.
引用
收藏
页码:696 / 706
页数:11
相关论文
共 50 条
  • [21] Lack of Discrepancy in Inflammatory Bowel Disease Hospitalization Outcomes Among Patients of Different Race or Ethnicity
    Dalal, Rahul S.
    Lichtenstein, Gary R.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S362 - S363
  • [22] Disparities in Inflammatory Bowel Disease Outcomes Based on Race and Insurance Status
    Ewelukwa, Ofor
    Njei, Basile
    Glover, Sarah
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S1281 - S1282
  • [23] Postoperative Outcomes in Vedolizumab-Treated Patients Undergoing Abdominal Operations for Inflammatory Bowel Disease
    Lightner, Amy
    Raffals, Laura
    Mathis, Kellie
    Cima, Robert
    Tse, Chung Sang
    Pemberton, John
    Dozois, Eric
    Loftus, Edward V.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 (02): : 185 - 190
  • [24] Patient Experiences and Outcomes of a Telehealth Clinical Care Pathway for Postoperative Inflammatory Bowel Disease Patients
    Zand, Aria
    Nguyen, Audrey
    Stokes, Zack
    van Deen, Welmoed
    Lightner, Amy
    Platt, Anya
    Jacobs, Rutger
    Reardon, Sarah
    Kane, Ellen
    Sack, Jonathan
    Hommes, Daniel
    TELEMEDICINE AND E-HEALTH, 2020, 26 (07) : 889 - 897
  • [25] Clinical Outcomes Following Postoperative Chemotherapy for Colorectal Adenocarcinoma in Patients With and Without Inflammatory Bowel Disease
    Dugum, Mohannad
    Markus, Johnathon
    Lin, Jingmei
    Estfan, Bassam
    Manilich, Elena
    Shen, Bo
    Liu, Xiuli
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S193 - S193
  • [26] Does Vedolizumab Affect Postoperative Outcomes in Patients Undergoing Abdominal Operations for Inflammatory Bowel Disease?
    Lightner, Amy
    Cima, Robert
    Pemberton, John
    Mathis, Kellie
    Chaudrey, Khadija
    Loftus, Edward, Jr.
    Raffals, Laura
    INFLAMMATORY BOWEL DISEASES, 2016, 22 : S46 - S47
  • [27] Hypoalbuminaemia and Postoperative Outcomes in Inflammatory Bowel Disease: the NSQIP Surgical Cohort
    Nguyen, Geoffrey C.
    Du, Lillian
    Chong, Rachel Y.
    Jackson, Timothy D.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 (11): : 1433 - 1438
  • [28] ASSOCIATION BETWEEN ANTIBIOTIC USE AND INFLAMMATORY BOWEL DISEASE OUTCOMES
    Liu, Luke
    O'Charoen, Sirimon
    Fehlmann, Tara
    Roedder, Silke
    Wendt, Emily
    Billin, Andrew
    Younis, Islam
    Iqbal, Shahed
    GASTROENTEROLOGY, 2023, 164 (04) : S42 - S42
  • [29] Association Between Provider Connectedness and Inflammatory Bowel Disease Outcomes
    Li, Yu Meng
    Stettler, Isabella
    Oungpasuk, Kanapath
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (08) : 1736 - 1737
  • [30] ASSOCIATION BETWEEN ANTIBIOTIC USE AND INFLAMMATORY BOWEL DISEASE OUTCOMES
    Liu, Luke
    O'Charoen, Sirimon
    Fehlmann, Tara
    Roedder, Silke
    Wendt, Emily
    Billin, Andrew
    Younis, Islam
    Iqbal, Shahed
    INFLAMMATORY BOWEL DISEASES, 2023, 29 : S33 - S34